MGA and non-small cell lung carcinoma: Here in the present study, we observed that mutations of MGA were associated with inflammatory response, JAK-STAT pathways, and interferon pathways, which might be part of the mechanism in predicting a better outcome of non-squamous NSCLC patients harboring MGA mutations after immunotherapy.